ANI Pharmaceuticals Inc (ANIP) – Company Profile and SWOT Analysis

ANI Pharmaceuticals Inc (ANIP) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

ANI Pharmaceuticals Inc (ANI) is a biopharmaceutical company. It focuses on developing, manufacturing and marketing generic and branded prescription pharmaceuticals. The company also offers over-the-counter (OTC) medicines and pharmaceuticals for rare diseases. ANI also conducts business as a contract development and manufacturing organization (CDMO) that assists in late-stage development to commercial manufacturing of pharmaceutical products, which include tablets and capsules, ointments, creams, liquids, oral suspensions, gels, injections, topical, powder and enema products. The company distributes its products through wholesalers, retail market chains, distributors and mail-order pharmacies, group purchasing organizations, specialty pharmacies and hospitals. ANI is headquartered in Baudette, Minnesota, the US.

Scope

• Detailed information on ANI Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting ANI Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of ANI Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about ANI Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of ANI Pharmaceuticals Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess ANI Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on ANI Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Apotex Inc

Amneal Pharmaceuticals Inc

Viatris Inc

Sun Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd

Glenmark Pharmaceuticals Ltd

Hikma Pharmaceuticals Plc

Par Pharmaceutical Inc

Alvogen Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

ANI Pharmaceuticals Inc - Key Facts

ANI Pharmaceuticals Inc - Key Employees

ANI Pharmaceuticals Inc - Key Employee Biographies

ANI Pharmaceuticals Inc - Major Products and Services

ANI Pharmaceuticals Inc - History

ANI Pharmaceuticals Inc - Company Statement

ANI Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

ANI Pharmaceuticals Inc - Business Description

Business Segment: Generics, Established Brands, and Other Segment

Overview

Performance

Business Segment: Rare Disease Segment

Overview

Performance

Geographical Segment: Canada

Performance

Geographical Segment: United States

Performance

ANI Pharmaceuticals Inc - Corporate Strategy

ANI Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

ANI Pharmaceuticals Inc - Strengths

ANI Pharmaceuticals Inc - Weaknesses

ANI Pharmaceuticals Inc - Opportunities

ANI Pharmaceuticals Inc - Threats

ANI Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

ANI Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Oct 30, 2024: ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

Oct 24, 2024: ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

Jun 25, 2024: ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

Feb 20, 2024: ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

Feb 07, 2024: ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET

Jan 29, 2024: ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Aug 23, 2023: ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors

Jul 31, 2023: ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

ANI Pharmaceuticals Inc, Key Facts

ANI Pharmaceuticals Inc, Key Employees

ANI Pharmaceuticals Inc, Key Employee Biographies

ANI Pharmaceuticals Inc, Major Products and Services

ANI Pharmaceuticals Inc, History

ANI Pharmaceuticals Inc, Other Locations

ANI Pharmaceuticals Inc, Subsidiaries

ANI Pharmaceuticals Inc, Key Competitors

ANI Pharmaceuticals Inc, Ratios based on current share price

ANI Pharmaceuticals Inc, Annual Ratios

ANI Pharmaceuticals Inc, Annual Ratios (Cont…1)

ANI Pharmaceuticals Inc, Annual Ratios (Cont…2)

ANI Pharmaceuticals Inc, Interim Ratios

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

ANI Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

ANI Pharmaceuticals Inc, Performance Chart (2019 – 2023)

ANI Pharmaceuticals Inc, Ratio Charts

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports